What Vertos Medical does

Vertos Medical, founded in 2005 and headquartered in Aliso Viejo, California, is a privately held medical device company specializing in minimally invasive treatments for lumbar spinal stenosis (LSS) and chronic low back pain. The company's core product is the mild® Procedure/System, a proprietary minimally invasive outpatient approach that removes small portions of bone and excess ligament tissue to relieve nerve compression in the lumbar spine and restore space in the spinal canal without significantly altering the structural anatomy. As of mid-2023, the mild® Procedure had been used to treat more than 70,000 patients in the United States, with reported clinical outcomes including an increase in average walking distance from 246 to 3,956 feet over one year post-procedure. Vertos holds a registered trademark on the mild® brand and operates within a focused single-indication portfolio.

Vertos generates revenue through hardware sales of the mild® device system to healthcare facilities — including hospitals, ambulatory surgery centers, and spine specialty clinics — using a direct enterprise field sales motion targeting physicians, pain management specialists, and spine surgeons. Pricing is established through standard healthcare procurement processes and is not publicly disclosed. Commercial adoption is supported by medical education, physician training programs, and industry conference participation. The company's customer base is segmented horizontally across the US healthcare provider landscape, with no single customer accounting for a disclosed share of revenue, and the company operates exclusively in the United States market with 101–250 employees.

The company has sustained venture-backed funding across 14 disclosed rounds from 2006 through 2023, with total disclosed capital raised exceeding $170 million. In June 2023, Vertos closed a $26 million oversubscribed Series C funding round led by Norwest Venture Partners with participation from Partner Ventures and Pitango VC, alongside a concurrent SEC-registered exempt securities offering of approximately $45.56 million. Earlier backers include MVM Life Science Partners, ONSET Ventures, CHL Medical Partners, DFJ Mercury, Foundation Capital, and Leerink Revelation Partners. In 2023, Vertos was recognized on the Deloitte Technology Fast 500 list, indicating rapid multi-year revenue growth as recognized by an external validator.

Name

Vertos Medical

Legal name

Vertos Medical Inc.

Website

https://vertosmed.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

101–250 employees

Short description

Vertos Medical is a US medical device company that develops and commercializes the mild® Procedure, a minimally invasive outpatient treatment for lumbar spinal stenosis. The company sells its devices directly to hospitals, ambulatory surgery centers, and spine specialty clinics nationwide.

Ownership category

akta.pro rank

Product category

Minimally Invasive Spine Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS) (HLAHADAA)

akta.pro secondary industry

Pain Management (Spine & Musculoskeletal) (HLAKALAM)

Keywords

• Minimally invasive spine devices
• Lumbar spinal stenosis treatment
• Outpatient spine procedures
• Medical device manufacturing
• Spinal decompression devices

Headquarters

HQ city

Aliso Viejo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales - mild® Procedure: Revenue generated from the sale of medical devices and procedures for treating lumbar spinal stenosis and chronic low back pain. The company has demonstrated rapid revenue growth with over 70,000 patients treated in the U.S.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Vertos Medical develops and markets the mild® System, a set of minimally invasive medical instruments used to perform the mild® Procedure for treating lumbar spinal stenosis (LSS). The procedure removes small portions of bone and ligament tissue through a small incision to relieve nerve pressure, and is typically delivered by pain management physicians or spine specialists in outpatient settings such as ambulatory surgery centers and office-based labs.

Product overview

Vertos Medical offers a focused portfolio of minimally invasive spine treatment solutions centered on its flagship mild® System and mild® Procedure. The company specializes in treating lumbar spinal stenosis (LSS) and chronic low back pain through outpatient procedures that remove small portions of bone and ligament to relieve nerve compression. The mild® Procedure has been used to treat over 70,000 patients in the United States.

Differentiator

Problem solved

Functional benefit

Brands

• mild®: Minimally invasive device and procedure for treating lumbar spinal stenosis (LSS) used in outpatient procedures that remove small portions of bone and ligament to relieve nerve compression.

Products and services

• mild® System

Quantifiable outcome

• Over 70,000 patients treated in the United States
• +1 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators3 records

Recent moves3 records

Expansion highlights4 records

Broad incumbents

• Stryker: Diversified medtech major whose Interventional Spine division directly references the mild® procedure alongside vertebral augmentation and basivertebral nerve ablation products, making it the most directly comparable incumbent in Vertos's LSS and interventional pain space.
• Boston Scientific: Acquired Vertiflex (Superion) to enter the LSS market and has a broader pain and neuromodulation portfolio, making it a key incumbent competing for the same physician customers and LSS patient population.
• Medtronic: Global spine leader with a comprehensive portfolio of surgical and interventional spine products, competing for hospital and ASC budgets and serving the same pain management and spine surgeon customers as Vertos.
• Globus Medical: Spine-focused medtech (now combined with NuVasive) with a broad MIS and interventional spine portfolio, competing with Vertos for the same hospital and ambulatory surgery center customers.
• Abbott: Spinal cord stimulation (Proclaim) and broader neuromodulation portfolio positioned as a downstream therapy for chronic low back and leg pain patients, often competing with or complementing mild® in the same treatment pathway.

Direct peers

• Vertiflex (now part of Boston Scientific): Developer of the Superion Indirect Decompression System, an interspinous spacer for moderate LSS—historically the most direct procedural alternative to mild® and now commercialized inside Boston Scientific.
• Relievant Medsystems: Maker of the Intracept procedure for vertebrogenic (basivertebral nerve) pain, an outpatient minimally invasive therapy targeting a closely overlapping LSS-adjacent patient population and physician call point.
• Spinal Simplicity: Developer of minimally invasive spine devices (including the Minuteman and Liberty products) targeting outpatient treatment of spinal stenosis and adjacent indications—a direct procedural and channel competitor to Vertos.

Emerging players

• SI-Bone: Specialist in minimally invasive sacroiliac joint fusion (iFuse), competing for the same pain management and interventional spine call point with an outpatient, MIS profile analogous to mild®.
• Alphatec Spine: Independent spine company focused on MIS and lateral approaches, competing with Vertos for surgeon mindshare and hospital/ASC accounts in the degenerative lumbar and LSS-adjacent segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vertos-medical-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds14 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vertos Medical